Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 16,069Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1BRECKENRIDGE PHARMS

02 1AJANTA PHARMA LTD

03 1AUROBINDO PHARMA LTD

04 1HIKMA

05 1MICRO LABS

06 2MSN PHARMS INC

07 2PF PRISM CV

08 3PFIZER

09 1PRINSTON PHARMA INC

10 2YAOPHARMA CO LTD

11 3ZYDUS PHARMS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed

TOFACITINIB

Brand Name : TOFACITINIB

Dosage Form : TABLET;ORAL

Dosage Strength : 5MG

Approval Date :

Application Number : 209633

RX/OTC/DISCN :

RLD :

TE Code :

Breckenridge Pharmaceutical

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

TOFACITINIB CITRATE

Brand Name : TOFACITINIB CITRATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 10MG BASE

Approval Date : 2021-06-01

Application Number : 212943

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

TOFACITINIB CITRATE

Brand Name : TOFACITINIB CITRATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 5MG BASE

Approval Date : 2023-03-13

Application Number : 209738

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

TOFACITINIB CITRATE

Brand Name : XELJANZ

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 5MG BASE

Approval Date : 2012-11-06

Application Number : 203214

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

TOFACITINIB CITRATE

Brand Name : XELJANZ

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 10MG BASE

Approval Date : 2018-05-30

Application Number : 203214

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

TOFACITINIB CITRATE

Brand Name : XELJANZ XR

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 11MG BASE

Approval Date : 2016-02-23

Application Number : 208246

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

TOFACITINIB CITRATE

Brand Name : XELJANZ XR

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 22MG BASE

Approval Date : 2019-12-12

Application Number : 208246

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

TOFACITINIB CITRATE

Brand Name : XELJANZ

Dosage Form : SOLUTION;ORAL

Dosage Strength : EQ 1MG BASE/ML

Approval Date : 2020-09-25

Application Number : 213082

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AA

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

TOFACITINIB

Brand Name : TOFACITINIB

Dosage Form : TABLET;ORAL

Dosage Strength : 5MG

Approval Date :

Application Number : 209923

RX/OTC/DISCN :

RLD :

TE Code :

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

TOFACITINIB CITRATE

Brand Name : TOFACITINIB CITRATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 5MG BASE

Approval Date : 2023-03-13

Application Number : 209829

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank